闽东农村婴幼儿腹泻病原学调查

对闽东农村５８２例婴幼儿腹泻患者进行细菌性病原调查，在２０８例腹泻患儿粪便中检出致泻菌２４６株，检出率为４２．２６％，其中ＥＴＥＣ７７株（１３．２３％），ＥＩＥＣ１９株（３．２６％），空肠弯曲菌１７株（２．９２％），沙门氏茵６株（１．０３％），亲水性气单胞菌２株（０．３４％）。表明致泻大肠杆菌（ＥＴＥＣ，ＥＰＥＣ，ＥＩＥＣ）是我区婴幼儿致泻主导菌群，占检出菌的６６．３％。混合感染率在农村腹泻患儿中高达１７．３％，值得临床工作者重视。     

Assessment of oxidative DNA damage in the oxyR-deficient SOS chromotest strain Escherichia coli PQ300.

The SOS chromotest is a simple short-term genotoxicity assay measuring the induction of gene sfiA in Escherichia coli K-12. The recent availability of SOS tester strains with additional mutations in DNA repair or protection systems allows testing of DNA damaging compounds for genotoxic specificity. E. coli PQ300 differs from the standard SOS tester strain PQ37 in that it contains an additional mutation in gene oxyR that renders it more sensitive to oxidative genotoxins. The generation of reactive oxygen intermediates (ROI) by hydroperoxides (H2O2, t-butyl hydroperoxide, cumene hydroperoxide), gamma-radiation, glucose oxidase, and xanthine oxidase resulted in a more vigorous SOS response in strain PQ300 compared to strain PQ37. PQ300 was also more sensitive than PQ37 for the detection of reducing agents such as ascorbic acid, cysteine, and glutathione, which also alter the redox status of the bacterial cells. However, intercalating agents (adriamycin, bleomycin, and mitomycin C) and the UV- and radiomimetic compound 4-nitroquinoline-1-oxide whose DNA damaging potential are known also to involve ROI did not show significant differences between strains PQ37 and PQ300. It is concluded that the oxyR-deficient strain PQ300 is useful for detecting certain classes of genotoxins that change the oxidative/antioxidative balance of tester bacteria in the SOS chromotest.     

Endophthalmitis at the Bristol Eye Hospital: an 11-year review of 47 patients

We reviewed data from 47 patients who were treated for endophthalmitis at our hospital during the 11-year period 1980-90. The most common clinical features were hypopyon (75%), diminished vision (72%), ocular pain (68%), discharge (57%), corneal oedema (51%), conjunctival injection (49%), abnormal red reflex (34%), corneal ulcer (32%) and corneal perforation (6%). A total of 54 isolates were obtained from 41 (87%) of the 47 patients. Gram-positive bacteria were more common (72%), than Gram-negative organisms (22%). Two cases were due to fungi, and herpes simplex virus was isolated from one case. The two most common Gram-positive organisms were coagulase-negative staphylococci (25%), and Staphylococcus aureus (11%), while Pseudomonas aeruginosa predominated among the Gram-negative bacteria isolated (15%). Mixed bacterial species were obtained from 29% of the infected patients, including one from whom Vibrio fluvialis was isolated. Predisposing factors included ocular surgery (60%)--mostly for cataract extraction (47%), penetrating trauma (15%) and periocular (15%) or systemic (11%) infections. All patients received antibiotics (generally chloramphenicol and/or a beta-lactamase-stable penicillin plus an aminoglycoside) prior to culture, when treatment was adjusted according to specific aetiological agents. Seventy-nine per cent of patients received topical or systemic steroids. Vitrectomy (diagnostic and therapeutic) was performed on 21% of patients. Sixty-three per cent of culture-positive patients lost vision (no perception of light) in the affected eye, compared to 17% of culture-negative cases (P < 0.05 Fisher exact test). Similarly, a better visual outcome (acuity of 6/12 or better) was associated with coagulase-negative staphylococcal infection than with streptococcal or fungal infections.(ABSTRACT TRUNCATED AT 250 WORDS)     

根管细菌渗漏体外模型的建立

目的：建立检测微细菌培养模型，以用于评价根管充填封闭情况。方法：牙根的冠根两端各连接一细菌培养储室，冠方储室置1mL无菌培养基并接种0．1mL菌液，根方储室起始为无菌培养基。每隔3d将冠方储室中菌液吸出1mL，并注入1mL新鲜BHI培养基，共90d。当根尖储室中培养基发生浑浊即为细菌渗漏发生，记录细菌渗漏发生时的天数。选择18个直根管前牙，其中牙胶充填组6个，用冷牙胶侧方加压充填技术充填；空管组6个，根管只预备不充填；根管密封组6个，根管充填并严密封闭根管口和根尖孔。用设计的模型检测密封状况。结果：全部空管组6个样本在1d内根方储室中出现浑浊；根管密封组6个样本的根方储室在90d内均未发生浑浊。牙胶充填组有2个样本分别在44d和46d发生浑浊。结论：此模型方法简单易行且实用有效，具有一定的临床相关性和可行性。     

小牛血清去蛋白注射液细菌内毒素检测方法的研究

目的：建立小牛血清去蛋白注射液的细菌内毒素检查方法。方法：根据2000年版《中国药典》进行试验。结果：小牛血清去蛋白注射液在2mg/ml浓度下进行细菌内毒素检查干扰现象，获得了可靠的数据和结果。结论：本品所采用的细菌内毒素检查方法灵敏、可靠。     

Fusidic acid viscous eyedrops – an evaluation of pharmacodynamics, pharmacokinetics and clinical use for UK optometrists

Recent changes in UK law have allowed UK-based optometrists to sell and supply fusidic acid viscous eyedrops, providing it is in the course of their professional activity and in an emergency. Alternatively, the optometrist may access fusidic acid viscous eyedrops, for a named patient, using a written order supplied to a pharmacy. This review provides details of the legal background to these changes, examines the common causes of a bacterial conjunctivitis, examines the mechanism of action of this narrow spectrum antibiotic as a bacteriostatic agent, reviews the susceptibility of common ocular isolates of bacteria to the drug and presents details of the expected pharmacokinetics of the viscous eyedrops. From this perspective, a systematic review is provided of the clinical studies which have investigated the use of fusidic acid viscous eyedrops and their outcome. The indicated use is generally for the treatment of bacterial conjunctivitis and/or blepharoconjunctivitis, especially that caused by Staphylococcus, but not Streptococcus or Haemophilus sp. (more likely associated with concurrent nasopharyngeal infections). The usual regimen for use is twice daily for 5-10 days, depending on severity, and can initially be used more intensively (four times per day). It may also be used for the management of corneal and conjunctival abrasions and foreign body injuries, or some cases of chronic blepharitis.     

阿米卡星与利福霉素钠注射液联合作为经验性治疗院外细菌性肺部感染首选方案的临床研究

目的　观察阿米卡星与利福霉素钠联合治疗院外细菌性肺部感染的疗效。方法　经临床确诊并有细菌性感染征象的院外肺部感染 3 0 0例 ,分为 3组 :治疗组 12 0例 ,予阿米卡星与利福霉素钠静脉滴注 ,每天 1次 ;对照 1组 80例 ,予青霉素与左氧氟沙星联合静脉滴注 ,每日 1次 ;对照 2组 10 0例 ,予青霉素与氨苄西林联合静脉滴注 ,每日 1次。观察有效率、显效所需时间及细菌清除率。结果　有效率治疗组为 98.3 3 % ,与对照 1组的88 75 %和对照 2组的 70 .0 0 %比较差异显著 (P均 <0 .0 1) ;显效时间治疗组为 (4.5± 2 .0 )天 ,对照 1组为 (6.5±3 .0 )天 ,对照 2组为 (8.0± 3 .0 )天 ,治疗组与后 2组相比差异显著 (P <0 .0 1) ;细菌清除率治疗组为 97.2 % ,对照 1组为 80 .0 % ,对照 2组为 72 .0 % ,治疗组与后 2组比较差异显著 (P <0 .0 1)。各组副作用均较小。结论　阿米卡星与利福霉素钠治疗院外细菌性肺部感染疗效好、疗程短、细菌清除率高、副作用小 ,可作为治疗院外细菌性肺部感染的首选经验方案     

Culturable and nonculturable bacterial symbionts in the toxic benthic dinoflagellate Ostreopsis lenticularis.

The toxic benthic dinoflagellate Ostreopsis lenticularis hosts a variety of symbiont bacterial flora. Laboratory cultured Ostreopsis clones require the presence of symbiotic Pseudomonas/Alteromonas bacterial strains for growth and toxicity development. Three culturable bacterial strains associated with Ostreopsis were identified as Pseudomonas/Alteromonas strain 1, Pseudomonas/Alteromonas strain 2 and Acinetobacter. Denaturing gradient gel electrophoresis (DGGE) analyses of extracted Ostreopsis associated bacterial DNAs indicated that there were three culturable and four non-culturable associated bacterial strains. The results presented here are the first report of the presence of unculturable bacterial symbionts in a toxic benthic dinoflagellate. Ostreopsis lost toxicity when exposed to elevated temperatures in the field and laboratory culture and subsequently recovered toxicity at reduced temperatures. Ostreopsis associated culturable Pseudomonas/Alteromonas bacterial strains were significantly reduced in dinoflagellate cultures exposed to elevated temperatures. The decreased toxicity of O. lenticularis exposed to elevated temperatures and their subsequent recovery of toxicity in periods of reduced thermal stress may have resulted from the effects of elevated temperature on the spectrum of culturable and unculturable bacterial species interacting with their Ostreopsis host.     

Interleukin 1 receptor antagonist (IL1RA) in acute leukaemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is a part of the acute phase reaction in patients with chemotherapy- induced leucopenia

Abstract: Blast cells derived from peripheral blood of patients with acute myelogenous leukaemia (AML) were cultured in vitro and interleukin 1 receptor antagonist (IL1RA) concentrations determined in culture supernatants. AML blasts derived from patients classified as AML-M4 and AML-M5 subtype showed an increased release of IL1RA. IL1α and IL1β caused a similar increase in AML blast release of IL1RA, and addition of anti-ILl antibodies decreased IL1RA release. IL1RA release from AML blasts was also increased by stem cell factor, tumour necrosis factor α (TNFα), granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor, whereas interleukin 3, interleukin 6, leukaemia inhibitory factor and granulocyte colony- stimulating factor did not significantly alter IL1RA release. When investigating IL1RA serum levels, serum concentrations were decreased in acute leukaemia patients with chemotherapy-induced cytopenia compared with healthy controls. Serum levels of both IL1RA as well as IL1β and soluble TNFα receptors increased when the leucopenic patients developed complicating bacterial infections.     

Endotoxin transfer through dialysis membranes: small- versus large-pore membranes.

In this in-vivo study, dialysate and serum endotoxin was evaluated before and after haemodialysis with small-pore (PS400) and large-pore (PS600) polysulphone dialysers, and before and after haemodiafiltration with the PS600 filter. The source of the endotoxin was the presence in dialysate of Pseudomonads at a concentration of 10(3)-10(4) CFU/ml. Endotoxin was measured by a modified chromogenic limulus amoebocyte lysate (LAL) assay. In spite of dialysate endotoxin concentrations greater than 100 pg/ml, no changes in pre- versus posttreatment LAL reactivity were observed in PS400 dialysis and PS600 haemodiafiltration. In contrast, PS600 haemodialysis was related to an increase in serum LAL reactivity from 1.3 +/- 1.5 to 3.8 +/- 2.0 pg/ml (n = 15, P less than 0.01), and five patients (33.3%) showed a post-dialysis value in excess of 5 pg/ml. Our data are consistent with the absence of in-vivo endotoxin transfer during haemodialysis with small-pore dialyser membranes, and during haemodiafiltration with membranes with larger pores. An increase in LAL reactivity during haemodialysis with membranes with larger pores is, however, present, presumably due to the occurrence of backdiffusion/filtration with that specific strategy.